INTRODUCTION
Sheep mast cell proteinase-1 (sMCP-1) is a member of the mast cell chymases, a group of serine proteinases with broadly chymotrypsin-like character. Other chymases have been described in human, rat, mouse and canine mast cells [1] [2] [3] [4] . sMCP-1 is expressed in ovine gastrointestinal mucosal mast cells (MMCs) [5] , and is unusual in that it has been found to cleave some substrates with trypsin-like specificity [6] .
The release of MMC chymases into the circulation and into the gut lumen occurs in rodents and sheep during nematode infection or after the induction of systemic anaphylaxis [7] . One of the most likely functions of MMC chymases is to increase epithelial permeability, since mouse mast cell proteinase-1 (mMCP-1) and sMCP-1 are detected in the lumen of the gut during nematode infections [8, 9] . Furthermore, using an ex i o perfusion system, the introduction of rat mast cell proteinase-2 (rMCP-2) into the mesenteric artery of rats caused increased jejunal mucosal permeability within minutes [10] . Increased mucosal permeability is thought to facilitate the translocation of anti-worm antibodies into the gut lumen [7] .
Our finding that sMCP-1 has trypsin-like properties, in addition to chymase activity, suggests that it may have some functions in common with tryptase. Human tryptase is a tetrameric serine proteinase, which is stabilized by strong electrostatic interactions with proteoglycans [11] . Some of the known functions of tryptase are fibrinogen degradation [12] , prostromelysin activation [13] and mitogenic activity for fibroblasts [14] , the latter activity not being observed with chymase [14] . Human tryptase is not inhibited by plasma serine proteinase inhibitors (serpins), nor by α # -macroglobulin (α # M), and remains active
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macroglobulin. The possibility that significant cleavage of plasma proteins could occur before sMCP-1 was inhibited was investigated using gel filtration and SDS\PAGE after adding sMCP-1 to plasma. Cleavage of ovine fibrinogen occurred in the presence of excess α " PI and α # -macroglobulin, the α-chain being cleaved C-terminally and the β-chain at the putative Lys-27. In addition, sMCP-1 was found to be mitogenic for bovine pulmonary artery fibroblasts, but was not mitogenic in the presence of soya-bean trypsin inhibitor. In terms of fibrinogen cleavage and fibroblast stimulation, sMCP-1 shows functional similarities to mast cell tryptase.
after prolonged incubation in plasma [15] . This is in contrast with our previous studies on the MMC chymases rMCP-2 and mMCP-1, which suggest that α " -proteinase inhibitor (α " PI) is highly effective in inhibiting both proteinases [16, 17] .
It was therefore of interest to determine whether sMCP-1, which, like rMCP-2 and mMCP-1, is abundantly expressed in gastrointestinal MMCs [7] , might be regulated in the same way, or like tryptase, be unaffected. In addition, sMCP-1, like tryptase [14] , is shown to be mitogenic for pulmonary fibroblasts.
MATERIALS AND METHODS

Materials
SMCP-1 [5] , equine neutrophil elastase [18] and rMCP-2 [19] were prepared as described previously. Bovine pancreatic trypsin was supplied by Boehringer-Mannheim. HPLC-grade solvents were obtained from Rathburn Chemicals Ltd., Walkerburn, Scotland, U.K. All other solvents and Coomassie Brilliant Blue R250 were obtained from BDH Laboratory Supplies Ltd. Unless otherwise stated, all chromatography columns and stationary phases were supplied by Pharmacia Biotech Ltd. All other reagents were purchased from Sigma Chemical Co.
Electrophoresis and N-terminal sequencing of proteins
SDS\PAGE was performed using the Mini-Protean II format (Bio-Rad), following the manufacturer's protocols. Samples for sequencing were separated by SDS\PAGE, using 10 % acrylamide Tris\Tricine gels [20] , then transferred to Immobilon-P membrane (Millipore) by semi-dry blotting with 10 mM 3-cyclohexylamino-1-propanesulphonic acid in 10 % methanol buffer at 75 mA\minigel for 1 h. Blots were stained with Coomassie Brilliant Blue R250 and bands of interest were sequenced by B. Dunbar, University of Aberdeen Protein Sequencing Facility, Aberdeen, Scotland, U.K., and P. Barker, Microchemical Facility, Babraham Institute, Cambridge, U.K.
Inhibitory effect of serum on sMCP-1, rMCP-2 and chymotrypsin
To dilutions (neat to 1 : 20) of sheep serum in PBS containing 0n1 % Brij 35 (BPS\Brij ; 40 µl) were added 10 µl of sMCP-1 (10n75 µM), rMCP-2 (18n8 µM) or chymotrypsin (18n0 µM). The mixtures were incubated at 25 mC for 24 min and residual activity with Suc-Ala-Ala-Pro-Phe-nitroanilide substrate was determined.
Purification of proteinase inhibitors from sheep serum
The following protocol was used to purify sheep α " PI [21] and the serpin previously termed α " PI [22] but now recognized as sheep contrapsin [23] . Sheep α # M was also purified. Ovine serum (9 ml) was fractionated on Blue Sepharose 6 Fast Flow (430 ml ; 50 mmi220 mm ; Pharmacia), equilibrated in 50 mM Tris\HCl, pH 7n5. The small first peak (high-M r -exclusion peak) contained α # M, and the larger later peak contained the serpins of interest ; the majority of ovine serum albumin remained bound to the column. (NH % ) # SO % (solid) was added to the exclusion peak at 4 mC to 50% saturation. The precipitate recovered by centrifugation was buffer-exchanged into 20 mM Tris\HCl, pH 7n5, and further purified by anion-exchange chromatography on Mono Q in 20 mM Tris\HCl, pH 7n5, with a 0-240 mM NaCl gradient. Fractions were monitored by reducing SDS\PAGE, and those containing a single band at approximate M r 180 000 were pooled as pure α # M. The main peak from Blue Sepharose chromatography of ovine serum was treated with solid (NH % ) # SO % at 4 mC to give 50 % saturation, and the supernatant after centrifugation was raised to 80 % saturation by further addition of (NH % ) # SO % . The solids obtained by centrifugation of the 50-80 % preparation were redissolved, then desalted into 20 mM Tris\HCl, pH 7n5. Anionexchange chromatography (Mono Q) was then performed on the preparation in 20 mM Tris\HCl, pH 7n5, with a 0-240 mM NaCl gradient. Fractions were monitored for trypsin-inhibitory capacity by incubating 50 µl of trypsin solution (30 µg\ml in 50 mM Tris\HCl, pH 7n5) with 10 µl of each sample for 5 min in microtitre plate wells, then adding 10 µl of substrate (10 mM N-Cbz-Arg-nitroanilide in DMSO). Inhibitory fractions were pooled and diluted 1 : 2 with 20 mM Tris\HCl, pH 8n5, for further chromatography on Mono Q at pH 8n5, with a 0-320 mM NaCl gradient. Fractions were monitored by reducing SDS\ PAGE, and those containing a protein of apparent M r 55 000 were combined and rechromatographed until a homogeneous α " PI preparation was obtained. Partial purification of a second serpin (sheep contrapsin ; apparent M r 123 000 by SDS\PAGE) was also achieved during the pH 8n5 separation, being eluted before α " PI.
Inhibitor kinetics : determination of association constant
sMCP-1 was active-site-titrated by the method of Jameson et al. [24] for chymotrypsin-like enzymes. The Spi1 variant of equine α " PI was purified from horse plasma known to be homozygous for the I haplotype of equine α " PI by the method of Pemberton et al. [25] . Equine elastase was active-site-titrated at pH 2n2 with Cbz-Ala-nitrophenyl ester, by the method of Kezdy and Kaiser [26] , and used to titrate equine α " PI. This inhibitor was used in titrations to determine the active-site concentrations of bovine pancreatic trypsin, bovine pancreatic chymotrypsin and rMCP-2. The molarities of sheep α " PI and sheep contrapsin were determined by titration against standardized bovine pancreatic trypsin stock.
For each determination, the proteinase and inhibitor were diluted in PBS\Brij to approximately equal concentration. To determine the association rate constant, typically 20 µl aliquots of inhibitor solution were added to 20 µl of proteinase in a semimicro polystyrene cuvette (BDH) and incubated for different lengths of time at 25 mC. After incubation, 140 µl of PBS\Brij was added, followed by 20 µl of the appropriate 4-nitroanilide substrate solution (10 mM in DMSO : Suc-Ala-Ala-Pro-Phenitroanilide for chymotrypsin, rMCP-2 and sMCP-1 ; MeOSucAla-Ala-Pro-Val-nitroanilide for equine elastase ; Cbz-Arg-nitroanilide for trypsin). The cuvette was agitated to mix well, then the rate of change of A %!& was measured over 1-2 min (Beckman DU 650 spectrophotometer). The experimental data were fitted to the theoretical model as described by Boudier and Bieth [27] .
Analysis of sMCP-1-α 1 PI complex for SDS/PAGE
sMCP-1 (2 µl of 0n5 mg\ml in PBS\Brij) was added to sheep α " PI (20 µl of 0n18 mg\ml in 20 mM Tris\HCl, pH 8n5) and incubated at 20 mC for 30 min. Non-reducing sample buffer (i.e. lacking 2-mercaptoethanol) (8 µl) was added and the mixture heated at 95 mC for 3 min to denature the enzyme. Reducing SDS sample buffer (30 µl) was then added and the sample was heated for a further 3 min at 95 mC, followed by analysis by SDS\PAGE.
Rabbit-anti-sMCP-1 polyclonal antibody
This was raised and affinity-purified as described previously [5] , and its specificity confirmed by Western blotting and immunohistochemistry as described [5] .
Western-blot analysis of sMCP-1 in the presence of serum, α 1 PI and α 2 M sMCP-1 (3 µl of 0n5 mg\ml in PBS\Brij) was incubated variously with sheep serum (1 µl), sheep α " PI (21 µl of 0n22 mg\ml in PBS) or sheep α # M (25 µl of 0n28 mg\ml in 20 mM Tris\HCl, pH 7n5) for 30 min at 25 mC. After incubation, 10 % SDS was added to the mixtures (and to controls lacking sMCP-1), to a total volume of 50 µl, which were then heated at 95 mC for 3 min. Samples were treated for SDS\PAGE with an equal volume of reducing sample buffer, and after electrophoresis of 10 µl aliquots, were electroblotted on to Immobilon-P membrane as described above. The blot was probed with affinity-purified rabbit anti-sMCP-1 IgG (see above ; 4 µg\ml), followed by alkaline phosphatase-conjugated monoclonal mouse anti-rabbit IgG (Sigma ; diluted 1 in 20 000). Finally, the blot was developed with 5-bromo-4-chloro-3-indolyl phosphate\NitroBlue Tetrazolium colour development substrate (Promega).
Analysis of plasma treated with sMCP-1
Sheep plasma (100 µl) was diluted with PBS (90 µl), then 10 µl of PBS or sMCP-1 (0n8 mg\ml) was added, and the mixture incubated at 20 mC for 15 min. Since the plasma concentration of sheep α " PI is approx. 1n6 mg\ml [21] , the incubation mixture contained an estimated 10-fold molar excess of α " PI over sMCP-1. The incubation mixture was then injected on to a gel-filtration column (Superose 12), eluted with PBS containing 3n8 % trisodium citrate at 1 ml\min, and fractions of 1 ml collected. All fractions were analysed by SDS\PAGE and for residual pro-teinase activity. The fraction containing degraded fibrinogen in the plasmajsMCP-1 incubation was separated by SDS\PAGE and blotted on to Immobilon-P membrane. Resolved fibrinogen bands were cut out for N-terminal amino acid sequencing.
Bovine pulmonary artery fibroblast culture
Fibroblast cultures were isolated from pulmonary arteries of adult cows using a primary explant procedure [28] . Cells were grown in Dulbecco's modified Eagle's medium supplemented with 10 % newborn calf serum, 100 U\ml penicillin and 100 µg\ml streptomycin and maintained at 37 mC in a humidified atmosphere of 95 % air\5 % CO # . Fibroblasts were utilized for experiments at passage levels 4-10 and rendered quiescent in serum-free Dulbecco's modified Eagle's medium for 48 h before treatment. 
Measurement of DNA synthesis
RESULTS
Titration of chymases with sheep serum
In order to determine whether sMCP-1, like the rodent MMC chymases, is inhibited by plasma serpins [16, 17] , the inhibitory effects of sheep serum on sMCP-1, rMCP-2 and chymotrypsin were compared. The addition of serum at increasing concentrations to the rat mast cell chymase rMCP-2 resulted in complete inhibition of the activity of this enzyme towards the nitroanilide substrate used. However, in the cases of chymotrypsin and sMCP-1, the residual amidolytic activity could not be reduced to less than approx. 10 and 20 % respectively (Figure 1 ).
Figure 1 Inhibition of sMCP-1, rMCP-2 and chymotrypsin by addition of sheep serum
Dilutions of serum were added to sMCP-1 (10n75 µM), rMCP-2 (18n8 µM) or chymotrypsin (chymo. ; 18n0 µM). After incubation at 25 mC for 24 min, residual hydrolytic activity was measured spectrophotometrically after the addition of Suc-Ala-Ala-Pro-Phe-4-nitroanilide. Fractional activity is plotted against serum protein concentration in each incubation.
Purification of sheep serum proteinase inhibitor
To characterize the native inhibitors of sMCP-1, three of the important proteinase-inhibitory components of ovine serum were purified. The α # M-like protein was shown by SDS\PAGE ( Figure  2 ) to have a subunit M r of approx. 177 000, and had substantial N-terminal sequence homology ( 50 %) with human α # M (Figure 3 ). Both α " PI and contrapsin [21, 22] were purified. The serpin with the lower M r (55 000 by SDS\PAGE ; Figures 2 and 4) was analogous to the α " PI described in other species in that it inhibited trypsin, chymotrypsin and leucocyte elastase (Table 1) , and had an N-terminal sequence identical with that reported by Mistry et al. [21] (Figure 3) . The other serpin (apparent M r l 123 000 by SDS\PAGE ; Figure 2 ) was larger than reported by Sinha et al. [22] (M r 62 000), but had the same inhibitory specificity for trypsin and an identical N-terminal sequence over the first 10 residues (Figure 3 ). This protein, initially described by Sinha et al. [22] , was more recently identified as sheep contrapsin by comparison with goat contrapsin (M r 60 000) [23] , which readily forms dimers as an artifact of SDS\PAGE analysis.
Inhibition kinetics
The purified sheep α " PI and the equine α I PI elastase inhibitor (Spi1) were similar in their second-order association rate constants with a range of serine proteinases. The order of k ass was the same in both : neutrophil elastase chymotrypsin rMCP-2 trypsin sMCP-1 (Table 1) . Importantly, both were rather slow inhibitors of sMCP-1. Contrapsin did not inhibit sMCP-1 or chymotrypsin (Table 1) , but was a very efficient inhibitor of trypsin (k ass l 2n2i10' M −" :s −" ), as has been described for goat contrapsin (k ass l 1n9i10' M −" :s −" ) [23] .
SDS/PAGE analysis of sMCP-1-α 1 PI complex-formation
Incubation of sMCP-1 with α " PI resulted in the formation of a complex band at approximate M r 80 000 by SDS\PAGE ( Figure  4 ). Minimal degradation of complex and\or residual α " PI occurred, as observed with rMCP-2-rat serpin incubations [16] , and in contrast with human chymase and rat mast cell proteinase-1, which both substantially hydrolysed α " PI [16, 30] .
Western-blot analysis of sMCP-1 in the presence of inhibitors
In order to determine which inhibitors complexed with sMCP-1 in ovine serum, the chymase was added as described in the Materials and methods section to serum, to purified α " PI and to purified α # M. The blots ( Figure 5 ) showed three sMCP-1-containing complex bands. One band of approximate M r 80 000 was found when sMCP-1 was incubated with serum and also with purified α " PI. Another two bands, of approximate M r 155 000 and 205 000, were seen in incubations of sMCP-1 with serum and with purified α # M ( Figure 5 ). The same results were observed when plasma was used in place of serum (results not shown).
Plasma protein degradation by sMCP-1
Because sMCP-1 was inhibited slowly by α " PI (k ass 1n1i10$ M −" :s −" ), it was possible that, when released systemically or into the tissues, sMCP-1 might exert significant proteolytic activity. Therefore sMCP-1 was added to plasma at a dilution 
Figure 3 N-Terminal amino acid sequences of inhibitors isolated from sheep serum
The α 1 PI-and contrapsin-like inhibitors are compared with the sheep serpin sequences reported by Mistry et al. [21] and Sinha et al. [22] respectively. The partial sheep α 2 M N-terminal sequence is aligned with that deduced for the human protein [29] . i, Residues that could not be assigned ; -, spaces inserted to improve sequence alignment.
ensuring inhibitor excess (see the Materials and methods section), which was confirmed after Superose 12 fractionation of the plasma, where residual chymotrypsin-like activity was associated only with the excluded peak containing α # M (results not shown). The only major change detected by SDS\PAGE of all the Superose 12 fractions was in the fraction containing fibrinogen. In the fibrinogen subunit pattern (Figure 6 ), the intensity of the α-chain band was much reduced. A band remained in the position of the β-chain (approximate M r 59 000), but amino acid sequencing showed that this contained the N-termini of both α-and β-chains, indicating C-terminal cleavage of the α-chain. The band that appeared at approximate M r 56 000 had an N-terminal sequence (Figure 7) corresponding to a conserved region of the β-chain, indicating cleavage of a peptide of approx. 27 residues from the N-terminus of the β-chain. The γ-chain was uncleaved at the N-terminus, and was found to be superimposed on Nterminal sequence for the α-chain, indicating further C-terminal cleavage of fibrinogen α-chain. 
Figure 6 SDS/polyacrylamide gel of fibrinogen-containing fractions from plasma with and without preincubation with sMCP-1
Samples (2 µl) of excluded fractions from Superose 12 gel filtration of plasma incubated with and without sMCP-1 were analysed on a 10 % gel. The lane marked ' sMCP-1k ' was from untreated plasma. The lane marked ' sMCP-1j ' was from plasma (100 µl) treated with sMCP-1 (10 µl of 0n8 mg/ml).
DNA synthesis in pulmonary artery fibroblasts
sMCP-1 stimulated the incorporation of [$H]-thymidine in a dose-dependent manner (Figure 8 ). This experiment was repeated on three occasions with similar results. Trypsin also stimulated incorporation, optimally at approx. 10-30 nM. At higher concentrations, trypsin caused detachment of fibroblasts from the plate. In order to determine whether the fibroblast stimulation required catalytically active enzyme, the effect of soya-bean trypsin inhibitor (STI) on proteinase-induced fibroblast DNA synthesis was investigated. Trypsin and sMCP-1 caused 12-and 7-fold increases respectively (P 0n05) in [$H]thymidine incorporation over control, and pretreatment of the proteinases with STI abrogated this effect ( Figure 9 ). In this experiment, chymotrypsin caused a slight increase in [$H]thymidine incorporation over control, but pretreatment of chymotrypsin with STI did not
Figure 7 N-Terminal sequence analysis of sheep fibrinogen β-chain cleavage
Bovine [31] , sheep and human [32] fibrinogen β-chain sequences are aligned at the conserved region, C-terminal to the thrombin-cleavage site (residue 21 in bovine β-chain). The unknown residues marked i are inserted to join the known sheep fibrinopeptide B sequence [33] with the N-terminal sequence observed here for sMCP-1-cleaved sheep fibrinogen β-chain (residues marked ? were obscured by an impurity during sequencing). Bovine fibrinogen β-chain was cleaved by sMCP-1 at residue 28 (H) [6] . reduce the level of [$H]thymidine uptake, indicating that this was due to an effect other than chymotryptic activity. The cells were also stimulated by 10 % newborn calf serum (results not shown), but not by soya-bean trypsin inhibitor and buffer-only controls.
DISCUSSION
Chymases derived from intestinal MMCs in rodents are thought to be important mediators of gut permeability and, at the same time, are released systemically into the bloodstream, where they are effectively inhibited by serpins [16, 17] . We have therefore purified α " PI, contrapsin and α # M from sheep serum in order to determine their interaction with sMCP-1. Two different serpins have been described as α " PI in sheep [21, 22] . One of these [21] is an inhibitor of M r 56 000 with substantial N-terminal amino acid sequence homology with and similar specificity to other mammalian α " PI (i.e. inhibition of leucocyte elastase and trypsin). The other inhibitor, of M r 62 000, is an efficient inhibitor of trypsin but not elastase, and has a lower N-terminal sequence homology with human α " PI [22] . This inhibitor was subsequently recognized as the sheep homologue of goat contrapsin by Potempa et al. [23] . The present study confirmed the presence of both inhibitors in sheep serum.
Figure 9 Effect of proteinases on [ 3 H]thymidine incorporation by bovine pulmonary artery fibroblasts
Mean valuespS.E.M. for triplicate determinations are shown. *Significant difference (P 0n05) in proteinase-treated fibroblasts compared with buffer-only controls. **Significant difference (P 0n05) in cells treated with STI-inhibited proteinases compared with uninhibited proteinases. sMCP-1, trypsin and chymotrypsin were used at final concentrations of 100 nM, 10 nM and 10 nM respectively with or without preincubation with STI at a concentration of 3 mg/ml for 5 min at 20 mC.
In common with human mast cell chymase [30] , sMCP-1 reacted slowly (k ass l 1n1i10$ M −" :s −" ) with sheep α " PI, although there was no evidence for substantial cleavage of α " PI, as was observed with human mast cell chymase [30] . Sheep contrapsin was a very efficient inhibitor of trypsin, but it showed no appreciable rate of complex-formation with chymotrypsin or sMCP-1. The contrapsins of ruminants and rodents are a subset of serpins with closer sequence similarity to α " -antichymotrypsin (α " AC) than to α " PI [23, 34, 35] , and are good inhibitors of trypsin, but not chymotrypsin and elastase. Interestingly, goat and bovine plasma contain other structurally related serpins, termed goat elastasin [23] and bovine elastase inhibitor [34] respectively. These are very effective inhibitors of elastase and chymotrypsin, both possessing Leu-Ser at P1-P1h in the reactivesite loop, in common with α " AC. No sheep homologues of elastasin or α " AC were observed during this study, but it is of note that sMCP-1 is not inhibited by human α " AC [6] , in contrast with human chymase [36] .
When titrated with sheep serum, the amidolytic activity of rMCP-2 decreased to undetectable levels, as a result of the efficient inhibition by sheep α " PI. However, the activity of sMCP-1 towards the nitroanilide substrate could not be reduced to zero by the addition of serum, even when the α " PI concentration was in great excess, because of inhibition by the panspecific proteinase inhibitor, α # M. The active site of the proteinase is not affected when trapped within and covalently linked to α # M [37] , permitting the observed cleavage of low-M r substrates.
Further evidence for sMCP-1 complexing with both α " PI and α # M was obtained by Western blotting of sMCP-1 to which serum, α " PI and α # M had variously been added. The absence of any other significant bands containing sMCP-1 immunoreactivity suggests that α " PI and α # M are the important inhibitors of sMCP-1 present in serum, and that sMCP-1 is partitioned between both inhibitors. A similar partition of human chymase between α # M and serpins has been observed by Schechter et al. [30] with human serum, where the serpins included both α " PI and α " AC.
The addition of sMCP-1 to plasma caused degradation of fibrinogen (Figure 6 ), despite the presence of excess α " PI and α # M. Fibrinogen α-chain was degraded by cleavage of a fragment of more than M r 5000 from the C-terminus. Hydrolysis of the β-chain was also observed, at a position corresponding to Lys-28 of bovine fibrinogen (Figure 7 ). This observation is supported by our finding that sMCP-1 cleaved purified bovine fibrinogen β-chain at this position [6] . Such a cleavage removes the GHR sequence (residues 22-24 of bovine β-chain), which is normally exposed when fibrinogen is cleaved by thrombin, and is important for polymerization to form fibrin. The γ-chain was uncleaved at the N-terminus, and underwent no obvious shift in M r by SDS\PAGE.
Mast cell chymases are not reported to stimulate cell growth, so it is particularly interesting that sMCP-1, at concentrations as low as 3 nM, stimulates DNA synthesis in bovine pulmonary artery fibroblasts. Tryptase, but not chymase, from dog mast cells is mitogenic for pulmonary fibroblasts [14] , which suggests that sMCP-1 may be mitogenic for bovine pulmonary artery fibroblasts by virtue of its trypsin-like properties, particularly since chymotrypsin was not mitogenic for these cells.
In summary, it has been demonstrated that the activity of sMCP-1 is controlled primarily by the serum inhibitors α " PI and α # M. The rate of inhibition is relatively slow, which may allow proteinase released into intercellular space sufficient opportunity to exert physiological effects by acting on a target substrate rather than being inhibited. Our in itro studies strongly suggest that, when released from the cell, sMCP-1 will cleave fibrinogen with trypsin-like specificity before it can be inhibited. The observed fibrinogen cleavages by sMCP-1 are likely to affect the nature of fibrin formed near sites of mast cell activation. Equally, during this window of activity, sMCP-1 may act like tryptase in its interaction with cell-surface substrates, for example, causing fibroblast proliferation. Thus sMCP-1, in addition to having dual chymase\tryptase substrate specificity, also has physiological properties in common with both chymase and tryptase.
